|
| 糖皮质激素性骨质疏松的防治进展 |
| Progress in the prevention and treatment of glucocorticoid induced osteoporosis |
| |
| DOI：10.3969/j.issn.1006-7108.2019.01.023 |
| 中文关键词: 糖皮质激素性骨质疏松 骨质疏松性骨折 防治进展 流行病学 |
| 英文关键词:glucocorticoid osteoporosis osteoporotic fracture prevention and treatment progress epidemiology |
| 基金项目:陕西省西安培华学院2017年校级科学研究重点项目（PHKT17020） |
|
| 摘要点击次数: 1481 |
| 全文下载次数: 538 |
| 中文摘要: |
| 糖皮质激素性骨质疏松作为一种继发性骨质疏松，发病率仅次于绝经后的骨质疏松症和老年性的骨质疏松症，是最常见的医源性疾病。糖皮质激素性骨质疏松症状隐匿，早期不易被发现，后期可能出现骨折、骨坏死等一系列并发症，如果得不到有效干预治疗，将会给患者带来极大的健康危险。本文对糖皮质激素性骨质疏松的流行病学及预防与治疗做一综述，旨在加强临床上对于糖皮质激素性骨质疏松防治工作的重视，并为进一步规范治疗提供参考。 |
| 英文摘要: |
| As a secondary osteoporosis，the morbidity of the glucocorticoid osteoporosis is next only to postmenopausal osteoporosis and senile osteoporosis.It is the most common iatrogenic disease. The symptoms of glucocorticoid are concealed. It's not easy to be discovered early. In the later period, there may be a series of complications such as fracture and osteonecrosis. If effective intervention is not available, it will bring infinite health risks to patients. This article reviews the epidemiology, prevention and treatment of glucocorticoid induced osteoporosis, aiming at reinforcing the emphasis on the prevention and treatment of glucocorticoid osteoporosis in clinical practice, and providing reference for further standardizing the treatment. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |